Zentek (CVE:ZEN) Stock Price Up 26.1% - Still a Buy?

Key Points

• Shares jumped 26.1% on Thursday to a high of C$0.92 (last C$0.87), with volume surging roughly 408% to about 336,524 shares versus an average of 66,271.
• The company has a market capitalization of C$93.56 million, a negative P/E of -10.88, and 50‑ and 200‑day moving averages of C$0.76 and C$0.94 respectively.
• Zentek is a graphene and nanomaterials developer, producing ZenGUARD antimicrobial coatings, PPE, rapid diagnostics and pursuing the Albany graphite project in Northern Ontario.

Zentek Ltd. (CVE:ZEN - ) shares rose 26.1% during trading on Thursday . The stock traded as high as C$0.92 and last traded at C$0.87. Approximately 336,524 shares changed hands during mid-day trading, an increase of 408% from the average daily volume of 66,271 shares. The stock had previously closed at C$0.69.

Zentek Stock Up 26.1%

The firm has a market capitalization of C$93.56 million, a P/E ratio of -10.88 and a beta of 0.34. The firm's 50-day moving average is C$0.76 and its 200 day moving average is C$0.94. The company has a debt-to-equity ratio of 15.41, a quick ratio of 7.59 and a current ratio of 1.00.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.